Nuclear Medicine: Page 371

More PET/CT lung masses seen with hardware-based fusion

By Eric Barnes

Two new studies underscore the superiority of PET/CT for imaging lung lesions compared to either modality alone. The first found that different fusion methods produce substantially different results, while the second found that PET/CT has higher sensitivity, specificity, and positive and negative predictive values than either modality alone for detecting lung metastases.

April 25, 2005

AuntMinnie.com Molecular Imaging Radiology Insider

By Jonathan S. Batchelor

April 24, 2005

PET/CT market on the rise

By AuntMinnie.com staff writers

The U.S. PET and PET/CT markets produced revenue of $496.6 million in 2004, according to a new report from market research firm Frost & Sullivan.

April 24, 2005

Neoprobe inks new Lymphoseek deal

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe of Dublin, OH, has signed an agreement with the University of California, San Diego that will enable the company to expand its Lymphoseek radiopharmaceutical into applications in ultrasound and optical imaging.

April 20, 2005

Molecular Insight raises $28 million

By AuntMinnie.com staff writers

Radioisotope imaging developer Molecular Insight Pharmaceuticals of Cambridge, MA, said it has raised $28 million in Series C financing.

April 19, 2005

Philips installs first hybrid SPECT/CT units

By AuntMinnie.com staff writers

Multimodality vendor Philips Medical Systems of Andover, MA, has completed the first installations of its Precedence hybrid SPECT/CT systems.

April 18, 2005